SURVIVAL AND TOXICITY UPDATE OF THE PHASE 2 TRIAL OF BEVACIZUMAB (BV) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) PATIENTS

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Desjardins, A; Reardon, DA; Peters, KB; Herndon, JE; Kirkpatrick, JP; Friedman, HS; Vredenburgh, JJ

Published Date

  • November 1, 2010

Published In

Volume / Issue

  • 12 /

Start / End Page

  • 77 - 77

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference

Conference Location

  • Hollywood, FL

Conference Start Date

  • December 9, 2010

Conference End Date

  • December 12, 2010